王宁玲律师现任本所上海办公室管理合伙人,她在知识产权各领域具有20多年的丰富经验。其业务涉及专利申办、出具法律意见、尽职调查、客户咨询、许可及专利诉讼,主要业务领域包括化学、化工、制药、医疗设备、半导体材料、3D打印以及纳米技术。
王律师在为跨国公司及中国公司提供知识产权组合管理法律意见、开展尽职调查、提供许可、诉讼和商业秘密保护与维权服务等方面拥有丰富的经验。她参与过多起美国国际贸易委员会(U.S. International Trade Commission,ITC)和美国地区法院的案件,并帮助海外企业在中国进行知识产权维权,包括以司法和海关途径进行维权。
王律师经常在中国和国际会议和研讨会上就专利相关议题发表演讲。她曾在中国人民大学法学院任教美国知识产权法的研究生课程,在上海交通大学凯原法学院任教美国知识产权法的研究生课程并主持专利模拟法庭,在中国科学技术大学担任法律课程项目教授。她目前担任大连理工大学法学院兼职教授。
王律师被《Intellectual Asset Management》评选为中国地区专利交易,专利申办及诉讼业务领域领军律师。《IAM Strategy 300》将她列为顶级知识产权策略师,以表彰其在制定和实施知识产权组合价值最大化战略方面的领先地位。《World IP Review》将她列为世界知识产权评论-中国专利领域领军人。
NOTE: No aspect of these rankings has been approved by the Supreme Court of New Jersey. Further information on methodologies is available via these links.
某特定模块化LED显示面板及其组件案,337-TA-1114(国际贸易委员会)。为多家中国LED企业和其在美国的子公司辩护。
Certain Light Emitting Diode Chips, Laser Diode Chips and Products Containing Same
Defended five Chinese LED companies in ITC litigations.
337-TA-674, ITC, Judge Luckern
Certain Sulfentrazone, Sulfentrazone Compositions, and Processes for Making Sulfentrazone
Defended two Chinese agro-chemical companies, defeating a petition for a temporary exclusion order and prevailing at trial, holding the patent invalid and not infringed.
337-TA-914, ITC, Judge Lord
Certain Plant-Derived Recombinant Human Serum Albumins ("rHSA") and Products Containing Same
337-TA-1238, ITC, Judge McNamara
Prosecuting patents for startup Hutchison Medipharma
Finnegan prepared and prosecuted patents for startup Hutchison Medipharma in the United States for the treatment of metastatic colorectal cancer. Those patents cover a small molecule, fruquintinib, which received approval in China.
Two-Way Radio Equipment and Systems, Related Software, and Components Thereof
337-TA-1053, ITC, Judge McNamara
Certain Short-Wavelength Light Emitting Diodes, Laser Diodes and Products Containing Same
337-TA-640, ITC, Judge Luckern
Event
2024 LES Thailand Annual Conference: Cutting-Edge Strategies for Global IP Licensing 2024 LES Thailand Annual Conference: Cutting-Edge Strategies for Global IP Licensing
February 16, 2024
Bangkok
Event
Power-Nation Institute Training Program Power-Nation Institute Training Program
October 27, 2023
Nanging
Event
Intellectual Property Internationalization Talent Training Course Intellectual Property Internationalization Talent Training Course
July 28-30, 2023
Beijing
Event
12th Pesticide Intellectual Property and Technology Innovation Conference 12th Pesticide Intellectual Property and Technology Innovation Conference
July 19-21, 2023
Qingdao
Event
21st Advanced Summit on Life Sciences Patents 21st Advanced Summit on Life Sciences Patents
May 18-19, 2023
New York
Media Mention
Finnegan Shortlisted for the 2024 Asian Legal Business China Law Awards Finnegan Shortlisted for the 2024 Asian Legal Business China Law Awards
April 25 2024
Asian Legal BusinessCommentary
Under the Evolving Intellectual Property Landscape in the U.S. and China, How Chinese Tech Companies Address Overseas Challenges Under the Evolving Intellectual Property Landscape in the U.S. and China, How Chinese Tech Companies Address Overseas Challenges
April 11, 2024
China Science and Technology News NetworkAward/Ranking
Seven Finnegan Partners Named IAM Global Leaders for 2024 Seven Finnegan Partners Named IAM Global Leaders for 2024
November 14, 2023
IAMPress Release
Managing Intellectual Property IP Stars: Finnegan Scores Top Patent Rankings Across the Board Managing Intellectual Property IP Stars: Finnegan Scores Top Patent Rankings Across the Board
July 13, 2023
Managing Intellectual PropertyPress Release
Finnegan Receives Top Rankings from Intellectual Asset Management; 46 Attorneys Ranked Finnegan Receives Top Rankings from Intellectual Asset Management; 46 Attorneys Ranked
June 30, 2023
Intellectual Asset Management担任俄勒冈州联邦地方法院Ann Aiken法官的法务助理
中文, 英文
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.